reports
- ABGSC Capital Goods Research
- Anders Idborg
- Karl Bokvist
- ABGSC Capital Goods Research
- Benjamin Wahlstedt
- Fredrik Ivarsson
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
- Filipe Botelho
- Haidje Rustau
- Jayanth Kandalam
- Peter Low
- Si Yong Ng
- ABGSC Oil & Oil Services Research
- John Olaisen
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
- ABGSC Oil & Oil Services Research
- John Olaisen
TGS Quarterly Dividend
TGS Quarterly Dividend OSLO, NORWAY (17 July 2025) – Following the authorization from the Annual General Meeting on 8 May 2025, the Board of TGS ASA has resolved to distribute a quarterly dividend of the NOK equivalent of USD 0.155 per share (NOK 1.58 per share) in Q3 2025. Key information relating to the cash dividend: Dividend amount and declared currency: USD 0.155 per share (equivalent to NOK 1.58 per share)Last trading day including right: 23 July 2025 Ex-date: 24 July 2025Record date: 25 July 2025Payment date: 7 August 2025 Date of approval: 16 July 2025 About TGS TGS ...
TGS announces Q2 2025 results
TGS announces Q2 2025 results Financial highlights: Multi-client revenues impacted by several library data purchases being postponed and low client commitment to ongoing projectsChallenging operational conditions for a large contract project and lower than expected JV partner participation for certain multi-client programs negatively affected contract revenuesOrder inflow of USD 133 million during Q2 2025 – total order backlog of USD 425 millionNet cash flow of USD 11 million in Q2 2025, compared to USD -13 million in Q2 2024Maintaining a stable dividend payment of USD 0.155 per share to b...
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quart...
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2025 Company Announcement Net sales of DARZALEX® in the second quarter of 2025 totaled USD 3,539 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.) COPENHAGEN, Denmark; July 16, 2025 – (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX (daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj, sold under the tradename DARZALEX FASPRO® in the U.S.), as reported by J&J were USD 3,5...
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
- ABGSC IT Research
- Herman Caspersen
- Øystein Elton Lodgaard
- ABGSC Capital Goods Research
- Anders Idborg
- Karl Bokvist
- Jerôme Bodin
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
MC LVMH MOET HENNESSY LOUIS VUITTON SE
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
EL ESSILORLUXOTTICA SA
PSM PROSIEBENSAT.1 MEDIA SE
BRBY BURBERRY GROUP PLC
KER KERING SA
ENI ENI S.P.A.
01913 PRADA S.P.A.
REP REPSOL SA
SUN SULZER AG
AALB AALBERTS N.V.
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
MONC MONCLER SPA
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
BRAV BRAVIDA HOLDING AB
BP. BP P.L.C.
THEP THERMADOR HOLDING SA
SHEL SHELL PLC
- Jerôme Bodin
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
MC LVMH MOET HENNESSY LOUIS VUITTON SE
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
EL ESSILORLUXOTTICA SA
PSM PROSIEBENSAT.1 MEDIA SE
BRBY BURBERRY GROUP PLC
KER KERING SA
ENI ENI S.P.A.
01913 PRADA S.P.A.
REP REPSOL SA
SUN SULZER AG
AALB AALBERTS N.V.
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
MONC MONCLER SPA
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
BRAV BRAVIDA HOLDING AB
BP. BP P.L.C.
THEP THERMADOR HOLDING SA
SHEL SHELL PLC
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
- Hela Zarrouk
- Hela Zarrouk
- Christophe Chaput
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.